secwatch.observer — SEC 8-K summary
======================================

Issuer:     GLAUKOS Corp (GKOS)
CIK:        0001192448
Form:       8-K
Filed at:   2025-10-29T23:59:59+00:00
Accession:  0001104659-25-103722
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Glaukos Q3 revenue $133.5M (+38% YoY); raises 2025 guide, introduces 2026 outlook
--------------------------------------------------------------------------------

- Record net sales $133.5M, up 38% YoY; U.S. Glaucoma sales $80.8M (+57% YoY).
- GAAP net loss $16.2M (($0.28)/share) improved from $21.4M loss prior year; non-GAAP loss $9.2M (($0.16)/share).
- Raised FY2025 net sales guidance to $490-495M (from $480-486M); introduced preliminary FY2026 guidance $600-620M.
- Gross margin ~78% (non-GAAP ~84%); ended quarter with $277.5M cash, no debt.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1192448/000110465925103722/0001104659-25-103722-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1192448/000110465925103722/gkos-20251029x8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-103722

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer